The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Major depressive disorder is one of the leading causes of disability in the world. Effective treatment guidelines have been developed and disseminated; however, unlike other fields of medicine, psychiatry has been slow to adapt and utilize these empirically validated treatment strategies. Measurement-based care (MBC) provides a simple way to use the established clinical treatment guidelines to provide optimal personalized evidence-based medical care. MBC is simple and easy to implement. At the core of MBC is the longitudinal measurement of symptom severity, adherence to treatment, medication tolerability, and patient safety. For a variety of reasons, published antidepressant treatment guidelines have not been adopted by most prescribing physicians. MBC offers a solution to many of the concerns that have led to the lack of integration of evidence-based clinical practice guidelines into standard care. MBC offers physicians the opportunity to provide optimal personalized evidence-based medical care to patients requiring antidepressant treatment.